| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5de66fcc7c37934b48c684ca26e9cc0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-75 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 |
| filingDate |
2018-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce10b67218bd40678760e2f0acf12a0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c56bcf000da04621dc6b8598c6dafe16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13b24e13ba54084d580347e4ff1d99bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5293ca49e8d5bc95e91643aab805e39 |
| publicationDate |
2020-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NL-2021591-B1 |
| titleOfInvention |
MuSK activation |
| abstract |
Novel methods for treating a condition or disorder associated with impaired neuromuscular transmission, such as MuSK myasthenia gravis (MuSK MG), in a subject are provided herein. Novel methods for treating a symptom associated with impaired neuromuscular transmission in a subject are also provided. The invention also provides mu|tiva|ent binding agents for use in treating the same. |
| priorityDate |
2018-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |